Wenhai Deng

755 total citations · 1 hit paper
29 papers, 476 citations indexed

About

Wenhai Deng is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Wenhai Deng has authored 29 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Wenhai Deng's work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (4 papers). Wenhai Deng is often cited by papers focused on Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (4 papers). Wenhai Deng collaborates with scholars based in China, United States and Hong Kong. Wenhai Deng's co-authors include Xiao‐Ping Zhong, Jimin Gao, Jinwook Shin, Jialong Yang, Weijian Sun, Shang Wang, Xian Shen, Wen Lei, Jinhong Wu and Yingpeng Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Chemosphere.

In The Last Decade

Wenhai Deng

26 papers receiving 472 citations

Hit Papers

Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cupr... 2024 2026 2025 2024 25 50 75

Peers

Wenhai Deng
Wenhai Deng
Citations per year, relative to Wenhai Deng Wenhai Deng (= 1×) peers Crina Stăvaru

Countries citing papers authored by Wenhai Deng

Since Specialization
Citations

This map shows the geographic impact of Wenhai Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhai Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhai Deng more than expected).

Fields of papers citing papers by Wenhai Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenhai Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhai Deng. The network helps show where Wenhai Deng may publish in the future.

Co-authorship network of co-authors of Wenhai Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenhai Deng. A scholar is included among the top collaborators of Wenhai Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenhai Deng. Wenhai Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lei, Wen, Wenhai Deng, Wenxia Gao, et al.. (2025). Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial. Nature Cancer. 6(5). 786–800. 14 indexed citations
3.
Deng, Wenhai, Shuaibin Wang, Yongyong Lu, et al.. (2025). Hyaluronic acid-modified doxorubicin-covalent organic framework nanoparticles triggered pyroptosis in combinations with immune checkpoint blockade for the treatment of breast cancer. International Journal of Biological Macromolecules. 310(Pt 3). 143265–143265. 2 indexed citations
4.
Cai, Yixin, Danying Zheng, Xiaoli Chen, et al.. (2025). An integrated multi-omics analysis identifies protein biomarkers and potential drug targets for psoriatic arthritis. Communications Biology. 8(1). 240–240. 3 indexed citations
5.
Zheng, Zhikun, Yizhou Xu, Wenhai Deng, et al.. (2025). An Fe(III)-covalent organic framework (COF)–sorafenib nanoplatform induces chemo-ferroptosis for enhanced hepatocellular carcinoma immunotherapy. Materials Today Bio. 34. 102135–102135. 4 indexed citations
6.
Lu, Xufeng, Wenhai Deng, Shuaibin Wang, et al.. (2024). PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy. Materials Today Bio. 29. 101317–101317. 13 indexed citations
7.
Lei, Wen, et al.. (2024). CD70-specific CAR NK cells expressing IL-15 for the treatment of CD19-negative B-cell malignancy. Blood Advances. 8(11). 2635–2645. 23 indexed citations
8.
Wang, Xiang, Xinxin Yang, Wenhai Deng, et al.. (2024). Engineering metal-organic framework nanoparticles trigger pyroptosis to boost colon cancer immunotherapy. Materials & Design. 238. 112731–112731. 7 indexed citations
9.
Hao, Yuanyuan, Panpan Chen, Mengyuan Li, et al.. (2023). Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-β signaling. Frontiers of Medicine. 18(1). 128–146. 11 indexed citations
11.
Li, Kang, Xiumei Wei, Wenhai Deng, et al.. (2023). Glutamine Metabolism Underlies the Functional Similarity of T Cells between Nile Tilapia and Tetrapod. Advanced Science. 10(12). e2201164–e2201164. 27 indexed citations
12.
Luo, Qian, Xiaoxia Wang, Wenhai Deng, et al.. (2023). Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia. Frontiers in Immunology. 14. 1093750–1093750. 29 indexed citations
13.
Cai, Yixin, Yiqing Wu, Jie Liu, et al.. (2023). Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study. BMC Cancer. 23(1). 1188–1188. 5 indexed citations
14.
Hu, Kai-Lun, Zimiao Chen, Xiaoxue Li, et al.. (2022). Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction. Reproductive Biology and Endocrinology. 20(1). 81–81. 21 indexed citations
15.
Hu, Kai-Lun, Zimiao Chen, Wenhai Deng, et al.. (2022). Diagnostic Value of Kisspeptin Levels on Early Pregnancy Outcome: a Systematic Review and Meta-analysis. Reproductive Sciences. 29(12). 3365–3372. 3 indexed citations
16.
Li, Xue, Mingzhu Zhao, Jingru Shi, et al.. (2021). Chrysene, a four-ring polycyclic aromatic hydrocarbon, induces hepatotoxicity in mice by activation of the aryl hydrocarbon receptor (AhR). Chemosphere. 276. 130108–130108. 23 indexed citations
17.
Wang, Yi, Hui Deng, Yihuai Pan, et al.. (2021). Periodontal disease increases the host susceptibility to COVID-19 and its severity: a Mendelian randomization study. Journal of Translational Medicine. 19(1). 528–528. 23 indexed citations
18.
Shi, Zhe, Xiaoxiao Wang, Rong Cheng, et al.. (2019). Phenanthrene, but not its isomer anthracene, effectively activates both human and mouse nuclear receptor constitutive androstane receptor (CAR) and induces hepatotoxicity in mice. Toxicology and Applied Pharmacology. 378. 114618–114618. 28 indexed citations
19.
Chen, Pengcheng, Wenhai Deng, Dandan Li, et al.. (2019). Circulating Mucosal-Associated Invariant T Cells in a Large Cohort of Healthy Chinese Individuals From Newborn to Elderly. Frontiers in Immunology. 10. 260–260. 44 indexed citations
20.
Deng, Wenhai, Jialong Yang, Xingguang Lin, et al.. (2016). Essential Role of mTORC1 in Self-Renewal of Murine Alveolar Macrophages. The Journal of Immunology. 198(1). 492–504. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026